Olivier Loeillot, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 12,946 shares at $190.00 ($2.5M) on 2026-09-24, disclosed to the SEC on 2026-09-25.
Scheduled sale ($2.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.00 | 4,542 | $863K | 35.1% |
| 2 | $190.00 | 8,404 | $1.6M | 64.9% |
| Total | $190.00 avg | 12,946 | $2.5M | 100% |
| Filing → |
| RGEN | SELL | 2026-09-08 | $504K | — | Filing → |
| RGEN | SELL | 2026-08-21 | $977K | — | Filing → |
| RGEN | SELL | 2026-04-22 | $536K | — | Filing → |